Compare stocks

ONWARD Medical N.V. is a medical technology company specializing in spinal cord stimulation therapies aimed at restoring movement, function, and independence for individuals with spinal cord injuries (SCI) and other movement disabilities. Founded in 2014 by researchers at the Swiss Federal Institute of Technology (EPFL), the company is headquartered in Eindhoven, the Netherlands, with additional offices in Lausanne, Switzerland, and Boston, Massachusetts. Its product portfolio includes the ARC-EX System, a non-invasive device designed to enhance upper limb function, and the investigational ARC-IM System, an implantable solution targeting blood pressure stability and other SCI-related symptoms. In 2024, ONWARD Medical secured exclusive rights to develop and commercialize the WIMAGINE Brain-Computer Interface (BCI), positioning the company to integrate thought-driven movement capabilities into its therapies. The company has also received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA) for its innovative approaches to SCI treatment.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.